Skip to main content
Skip to main navigation
Invalid credentials.
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical R&D
Biopharmaceutical Sales & Marketing
Biosimilars
Healthcare Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Cardiovascular
Central Nervous System
Diabetes & Endocrinology
Infectious Diseases
Internal Medicine
Oncology
Early Phase Oncology
Translational Oncology
Pediatrics
Public Health Interest
Vaccines
Other Therapeutic Areas
Our Focus
Our Values
Our Heritage
Our Perspectives
Our Leadership
Ethics & Compliance
Investors
United States
Phone:1-866-267-4479
Request a Proposal
Phone:0-800-89-0011
Phone:0-800-99-1011
Email:commercial.germany@quintiles.com
Phone:0621-84508-113
Phone:1-800-881-011
Email:info@quintiles.com
Phone:0-800-555-4288
Email:clinical@quintiles.at
Phone:0-800-200-288
Email:commercial.bd.be@quintiles.com
Phone:+32 2 555 05 55
Phone:0-800-890-0288
Phone:00-800-0010
Phone:+1 514 855 0888
Phone:800-225-288
Email:asia@quintiles.com
Phone:10-811
Phone:01-800-911-0010
Phone:0-800-011-4114
Phone:0800-220-111
Phone:00-800-222-55288
Phone:800-100-10
Phone:2-0102247-3804
Phone:800-12001
Phone:0-800-11-0015
Phone:191
Phone:00-800-1311
Phone:999-9190
Phone:800-96-1111
Phone:06-800-011-11
Phone:000-117
Phone:001-801-10
Phone:1-800-550-000
Phone:1-80-949-4949
Email:qmil.clinical@quintiles.com
Phone:800-172-444
Email:qjpn.corpmktg@quintiles.com
Phone:00-539-111
Phone:8000-2288
Phone:
Phone:1-800-80-0011
Phone:800-901-10
Phone:01-800-288-2872
Phone:+31 23 567 0910
Phone:000-911
Phone:800-190-11
Phone:800-0109
Phone:0-800-50-288
Phone:1010-5511-00
Email:QWAW.Reception@quintiles.com
Phone:0-0-800-111-1111
Phone:800-800-128
Phone:0808-03-4288
Phone:8^10-800-110-1011
Phone:800-011-1111
Phone:0-800-000-101
Phone:0-800-99-0123
Phone:900-99-0011
Email:info.sweden@quintiles.com
Phone:020-799-111
Email:info@outcome.com
Phone:0-800-890011
Phone:00-801-102-880
Phone:1-800-0001-33
Phone:0811-288-0001
Phone:0^00-11
Phone:1-201-0288
Facebook Twitter LinkedIn YouTube
Dr. Cynthia L. Verst heads the global Phase IIIB/IV business segment for Quintiles’ a dedicated business that bridges the gap between peri-approval and commercialization of marketed therapies.
Dr. Verst brings more than 18 years of biopharma experience and a proven track record of late phase operational leadership and innovation. Most recently, she was Senior Vice President, Global Late Phase Research, for Ingenix, where she and her team successfully established a new global Late Phase Research Business Unit. Previously, Dr. Verst and her team established and led Kendle’s global Late Phase Business Unit. She began her career in biopharma at Procter & Gamble Pharmaceuticals as Section Head in its North American Medical and Technical Affairs group, successfully leading the Phase IIIB/IV research requirements of marketed products. Dr. Verst has been directly involved and/or provided executive level oversight to hundreds of Phase IIIB, IV, registries, comparative effectiveness, and Health Economic & Outcomes Research (HEOR) programs, entailing more than one million patients and more than 150,000 investigators in more than 60 countries.
A native of Kentucky, Dr. Verst holds a Pharm.D. and bachelor of science degree Pharmacy from the University of Cincinnati, an master of science in Structural and Cellular Biology from the University of Illinois, and a bachelor of science degree in Biology and Chemistry from Northern Kentucky University.